{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:44:37Z","timestamp":1788799477380,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T00:00:00Z","timestamp":1694217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jdcr.2023.08.044","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T22:32:55Z","timestamp":1694817175000},"page":"71-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Alopecia areata-like presentations with mogamulizumab therapy"],"prefix":"10.1016","volume":"41","author":[{"given":"Colin M.","family":"Kincaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0078-4322","authenticated-orcid":false,"given":"Ajay N.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3219-8253","authenticated-orcid":false,"given":"Bonnie A.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren C.","family":"Pinter-Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janellen","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4681-2452","authenticated-orcid":false,"given":"Kenneth","family":"Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha A.","family":"Mesinkovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jdcr.2023.08.044_bib1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/14737140.2020.1760096","article-title":"Mogamulizumab in the treatment of advanced mycosis fungoides and S\u00e9zary syndrome: safety and efficacy","volume":"20","author":"Lewis","year":"2020","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.jdcr.2023.08.044_bib2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jdcr.2021.10.034","article-title":"Alopecia areata after mogamulizumab treatment","volume":"19","author":"Raval","year":"2022","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jdcr.2023.08.044_bib3","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0959-8049(21)00719-X","article-title":"Is mogamulizumab-induced alopecia areata associated with favorable outcomes in S\u00e9zary syndrome?","volume":"156","author":"Amatore","year":"2021","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.jdcr.2023.08.044_bib4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/bjd.17320","article-title":"Association of autoimmunity and long-term complete remission in patients with S\u00e9zary syndrome treated with mogamulizumab","volume":"180","author":"Bonnet","year":"2019","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2023.08.044_bib5","doi-asserted-by":"crossref","DOI":"10.1007\/s13555-015-0083-4","article-title":"Invisible mycosis fungoides: not to be missed in chronic pruritus","volume":"5","author":"Deen","year":"2015","journal-title":"Dermatol Ther"},{"issue":"12","key":"10.1016\/j.jdcr.2023.08.044_bib6","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1586\/1744666X.2015.1085306","article-title":"The role of lymphocytes in the development and treatment of alopecia areata","volume":"11","author":"Guo","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"10.1016\/j.jdcr.2023.08.044_bib7","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/jamadermatol.2021.0877","article-title":"Clinical characterization of mogamulizumab-associated rash during treatment of mycosis fungoides or S\u00e9zary syndrome","volume":"157","author":"Hirotsu","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"9","key":"10.1016\/j.jdcr.2023.08.044_bib8","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S1470-2045(18)30379-6","article-title":"Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial","volume":"19","author":"Kim","year":"2018","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.jdcr.2023.08.044_bib9","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1097\/PAS.0000000000001587","article-title":"Histopathologic characterization of mogamulizumab-associated rash","volume":"44","author":"Wang","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.jdcr.2023.08.044_bib10","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1182\/bloodadvances.2020001641","article-title":"Robust CD8+ T-cell proliferation and diversification after mogamulizumab in patients with adult T-cell leukemia-lymphoma","volume":"4","author":"Saito","year":"2020","journal-title":"Blood Adv"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623003375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623003375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:25:58Z","timestamp":1762475158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512623003375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":10,"alternative-id":["S2352512623003375"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.08.044","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alopecia areata-like presentations with mogamulizumab therapy","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.08.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}